Page last updated: 2024-12-09

thiophene-3-boronic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

thiophene-3-boronic acid: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID581760
CHEMBL ID341722
SCHEMBL ID42265
MeSH IDM0527781

Synonyms (56)

Synonym
3-thiopheneboronic acid
3-thienylboronic acid, >=95.0%
thiophene-3-boronic acid
6165-69-1
3-thienylboronic acid
thiophen-3-ylboronic acid
STK502139
CHEMBL341722 ,
thiophene 3-boronic acid
AKOS000264851
T1975
bdbm50067902
A8543
NCGC00249454-01
NCGC00249454-02
BP-12791
FT-0616405
AM20100505
PB18451
(thiophen-3-yl)boronic acid
AS-3010
thiophen-3-yl-3-boronic acid
SCHEMBL42265
thiophen-3-yl boronic acid
3-thipheneboronic acid
thiophene-3-yl boronic acid
thiophen-3ylboronic acid
3-thiophene boronic acid
3-thiophenylboronic acid
3-thiophen-boronic acid
thien-3-yl boronic acid
3-thienyl boronic acid
thiophen-3-boronic acid
3-thiophenboronic acid
3-thienylboronicacid
3-thiophene-boronic-acid
3-thiophenyl boronic acid
3-thiophene-boronic acid
thiopen-3-boronic acid
thien-3-ylboronic acid
3-thienylboronic acid #
boronic acid, 3-thienyl-
AC-24797
F9995-1361
mfcd00151851
J-524955
CS-W001066
DTXSID60342433
(3-thienyl)boronic acid
3-thiopheneboronic acid, (contains varying amounts of anhydride)
BCP27592
SY014859
EN300-73578
3-thiophene boric acid
Z336079668
HY-W001066

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" The current signal produced by the released liposomal Fe(CN)6(4-), measured using square wave voltammetry, yielded a sigmoidally shaped dose-response curve that was linear over eight orders of magnitude (from 10(-11) to 10(-3)M)."( Improved activity of immobilized antibody by paratope orientation controller: probing paratope orientation by electrochemical strategy and surface plasmon resonance spectroscopy.
Annie Ho, JA; Liao, WC, 2014
)
0.4
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (2)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Beta-lactamaseEscherichia coli K-12Ki22.10000.02703.64137.3000AID38398
Angiotensin-converting enzymeRattus norvegicus (Norway rat)Ki22.10000.00011.96427.3000AID38398
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (2)

Processvia Protein(s)Taxonomy
antibiotic catabolic processBeta-lactamaseEscherichia coli K-12
response to antibioticBeta-lactamaseEscherichia coli K-12
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (2)

Processvia Protein(s)Taxonomy
beta-lactamase activityBeta-lactamaseEscherichia coli K-12
hydrolase activityBeta-lactamaseEscherichia coli K-12
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (2)

Processvia Protein(s)Taxonomy
outer membrane-bounded periplasmic spaceBeta-lactamaseEscherichia coli K-12
periplasmic spaceBeta-lactamaseEscherichia coli K-12
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (7)

Assay IDTitleYearJournalArticle
AID161063Residual binding of radiolabeled PGE-2 on the Prostanoid EP3 receptor at a concentration of 1 uM2001Bioorganic & medicinal chemistry letters, Mar-12, Volume: 11, Issue:5
Structure-activity relationship on the human EP3 prostanoid receptor by use of solid-support chemistry.
AID1127993Toxicity in Staphylococcus aureus ATCC 25923 at 100 ug/ml after 24 hrs by microdilution method2014Journal of medicinal chemistry, Mar-27, Volume: 57, Issue:6
First identification of boronic species as novel potential inhibitors of the Staphylococcus aureus NorA efflux pump.
AID1127994Toxicity in fluoroquinolone-resistant Staphylococcus aureus 1199B expressing NorA at 100 ug/ml after 24 hrs by microdilution method2014Journal of medicinal chemistry, Mar-27, Volume: 57, Issue:6
First identification of boronic species as novel potential inhibitors of the Staphylococcus aureus NorA efflux pump.
AID38398Inhibitory activity against Escherichia coli AmpC beta-lactamase.1998Journal of medicinal chemistry, Nov-05, Volume: 41, Issue:23
Structure-based enhancement of boronic acid-based inhibitors of AmpC beta-lactamase.
AID1127992Inhibition of NorA in fluoroquinolone-resistant Staphylococcus aureus 1199B assessed as potentiation of 4 ug/ml of ciprofloxacin MIC at 100 ug/ml after 24 hrs by microdilution method2014Journal of medicinal chemistry, Mar-27, Volume: 57, Issue:6
First identification of boronic species as novel potential inhibitors of the Staphylococcus aureus NorA efflux pump.
AID1127999Cytotoxicity against human KB cells assessed growth inhibition at 10 uM after 72 hrs by MTS assay2014Journal of medicinal chemistry, Mar-27, Volume: 57, Issue:6
First identification of boronic species as novel potential inhibitors of the Staphylococcus aureus NorA efflux pump.
AID1127995Toxicity in Staphylococcus aureus ATCC 25923 after 24 hrs by microdilution method2014Journal of medicinal chemistry, Mar-27, Volume: 57, Issue:6
First identification of boronic species as novel potential inhibitors of the Staphylococcus aureus NorA efflux pump.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (14.29)18.2507
2000's2 (28.57)29.6817
2010's4 (57.14)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 24.42

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index24.42 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.86 (4.65)
Search Engine Demand Index23.28 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (24.42)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]